Part D results
CMS's year-end Part D reconciliation, 2022–2024. When a plan's actual drug costs land well above its bid, CMS shares the loss through risk sharing (the "risk corridors"); when they land well below, the plan pays CMS back. A large positive amount means the plan's drug bid was badly underpriced. 2024 is the latest year CMS has published.
How to read this
Risk sharing: positive = CMS paid the plan (costs ran over the bid by more than the corridor); negative = the plan paid CMS. These are CMS's settled figures. Plans also report risk sharing in their MLR filings, sometimes as an estimate made before CMS settled, so a filing can differ.
Per member per year: risk sharing ÷ Part D member-months × 12. Part D member-months include stand-alone drug plan (PDP) members.
CMS's reconciliation also settles reinsurance (catastrophic drug costs) and low-income cost sharing; those are pass-through subsidies, not a sign of profit or loss, so they're shown on contract pages only.
| 2024 | 2023 | 2022 | 3-year total | Per member per year2024 | Part D members2024 avg | |
|---|---|---|---|---|---|---|
| H8330 Tufts Health Plan | $10.6M | −$1.8M | −$249K | $8.6M | $1,072 | 9,917 |
| H7419 Tufts Health Plan | $3.0M | $2.9M | $1.5M | $7.4M | $373 | 7,942 |
| H9907 Tufts Health Plan | $231K | $5.3K | — | $236K | $29 | 7,839 |
| H0342 CarePartners of Connecticut | −$124K | $94.2K | $119K | $88.4K | −$54 | 2,317 |
| S0655 Tufts Health Plan PDP | $0 | $0 | $0 | $0 | $0 | 9,262 |
| H5273 CarePartners of Connecticut | $0 | −$152K | −$129K | −$281K | $0 | 6,388 |
| H6750 Harvard Pilgrim Health Care of New England, Inc. | $927K | −$208K | −$1.3M | −$582K | $91 | 10,194 |
| H2256 Tufts Health Plan | $1.1M | −$3.3M | −$1.9M | −$4.2M | $11 | 96,818 |
Red = CMS paid the plan. Sorted by the 3-year total. Parent totals add up each contract under its current parent; CMS also publishes its own parent rollup, which can differ where contracts changed hands.